Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
Zhe Wang, Kun Zhao, Thilo Hackert, et al.
Frontiers in Cell and Developmental Biology (2018) Vol. 6
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
Elena Martín‐Orozco, Ana Sanchez-Fernandez, Irene Ortiz-Parra, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 232
FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell
Sébastien Relier, Julie Ripoll, Hélène Guillorit, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 124
Hyaluronan and Reactive Oxygen Species Signaling—Novel Cues from the Matrix?
Aikaterini Berdiaki, Monica Neagu, Ioanna Spyridaki, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 824-824
Open Access | Times Cited: 56
PDX-derived organoids model in vivo drug response and secrete biomarkers
Ling Huang, Bruno Bockorny, Indranil Paul, et al.
JCI Insight (2020) Vol. 5, Iss. 21
Open Access | Times Cited: 96
The key roles of cancer stem cell-derived extracellular vesicles
Chaoyue Su, Jianye Zhang, Yosef Yarden, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 94
Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment
Marina Marozzi, Arianna Parnigoni, Aide Negri, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8102-8102
Open Access | Times Cited: 93
ILC1 drive intestinal epithelial and matrix remodelling
Geraldine M. Jowett, Michael D. A. Norman, Tracy T. L. Yu, et al.
Nature Materials (2020) Vol. 20, Iss. 2, pp. 250-259
Open Access | Times Cited: 85
The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis
Theresa D. Ahrens, Sara R. Bang-Christensen, Amalie M. Jørgensen, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 75
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
Giuseppe Schepisi, Caterina Gianni, Michela Palleschi, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1597-1597
Open Access | Times Cited: 30
Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C44Mab-9 for Multiple Applications against Colorectal Carcinomas
Ryo Ejima, Hiroyuki Suzuki, Tomohiro Tanaka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4007-4007
Open Access | Times Cited: 25
Long noncoding RNA ABHD11-AS1 interacts with SART3 and regulates CD44 RNA alternative splicing to promote lung carcinogenesis
Po‐Shun Wang, Zulong Liu, Osama Sweef, et al.
Environment International (2024) Vol. 185, pp. 108494-108494
Open Access | Times Cited: 11
Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications
Pichaya Thanindratarn, Dylan C. Dean, Scott D. Nelson, et al.
Cancer Treatment Reviews (2019) Vol. 82, pp. 101934-101934
Closed Access | Times Cited: 60
CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice
Simona Porcellini, Claudia Asperti, Stefano Corna, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 60
Aneuploid Circulating Tumor-Derived Endothelial Cell (CTEC): A Novel Versatile Player in Tumor Neovascularization and Cancer Metastasis
Peter Ping Lin
Cells (2020) Vol. 9, Iss. 6, pp. 1539-1539
Open Access | Times Cited: 57
Involvement of hyaluronan and CD44 in cancer and viral infections
Paraskevi Heldin, Constantinos Kolliopoulos, Chun‐Yu Lin, et al.
Cellular Signalling (2019) Vol. 65, pp. 109427-109427
Closed Access | Times Cited: 55
Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo
Fernanda Andrade, Diana Rafael, Mireia Vilar-Hernández, et al.
Journal of Controlled Release (2021) Vol. 331, pp. 198-212
Closed Access | Times Cited: 48
The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance
Kalyani Patil, Khan Farheen Badrealam, Sabah Akhtar, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 3, pp. 691-720
Open Access | Times Cited: 48
CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations
Ling Tang, Hongming Huang, Yutong Tang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 30
Tumour associated endothelial cells: origin, characteristics and role in metastasis and anti-angiogenic resistance
Xinghong Yao, Ye Zeng
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 19
CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets
John Maher, David M. Davies
Cancers (2023) Vol. 15, Iss. 4, pp. 1171-1171
Open Access | Times Cited: 18
Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles
Marco Cavaco, Carolina Pereira, Bruna Kreutzer, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2016) Vol. 110, pp. 76-84
Closed Access | Times Cited: 54
CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells
Corinna Haist, Elena Schulte, Nina Bartels, et al.
Oral Oncology (2021) Vol. 116, pp. 105259-105259
Closed Access | Times Cited: 34
Overexpression of CBS/H2S inhibits proliferation and metastasis of colon cancer cells through downregulation of CD44
Yuyang Zhang, Shan-Wen Chen, Jing Zhu, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 24
CD44 promotes angiogenesis in myocardial infarction through regulating plasma exosome uptake and further enhancing FGFR2 signaling transduction
Qing Zhang, Li Chen, Liyi Huang, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 24
Cell-in-cell structure mediates in-cell killing suppressed by CD44
Yan Su, Hongyan Huang, Tianzhi Luo, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top